ʻO ka weheweheʻana
ʻO keʻano molecular o kēia waena waena o kēia waena he c7h7nos, a me kona mau molele molular he 153.2. ʻO kānaʻano hana hoʻohālikelike e pāʻani ana i kahi hana koʻikoʻi i ka hanaʻana o fsbuxostat e like me ka mea nui i ke kaʻina synthesis synthesis synthesis. ʻO kēia waena waena he mea nui loa i ka hanaʻana o fsbuxostat, iʻikeʻia no kona hikiʻana i ka nui o nā'ōmole unich.
ʻO Paranddroxexenthiebenzamide ka mea i hoʻohana pinepineʻia ma kaʻoihana lāʻau lapaʻau i hoʻohanaʻia ma ka hana lāʻau lapaʻau no kāna hanaʻana i ka hana o nā lāʻau lapaʻau likeʻole. ʻO kāna helu kau he 25984-63-8-8,8, maʻalahi ka maʻalahi e hoʻomaopopo a nānā no nā noiʻi a me nā kumu hana. Hanaʻia kēia waena waena e hoʻokō i nā kūlana kūpono kūpono, e hōʻoia ana i kona maʻemaʻe a me ka hilinaʻi i loko o nā noi pharmaceturical.
Koho iā mākou
ʻO Jdk i nā hale hana mua o nā papa mua a me nā mea hoʻokele waiwai kūpono, e hōʻoia ana i ka nui o ka pono o ka API i kauʻia. ʻO ka hui loea e hoʻopiʻi iā R & D o ka huahana. E kū'ē iā lāua, keʻimi nei mākou no CMM & CDMO ma ka hale kūʻai home a me ka mākeke honua.